MX9704253A - Derivados de 9-0-oxima de eritromicina o dotados con actividad antibiotica. - Google Patents
Derivados de 9-0-oxima de eritromicina o dotados con actividad antibiotica.Info
- Publication number
- MX9704253A MX9704253A MX9704253A MX9704253A MX9704253A MX 9704253 A MX9704253 A MX 9704253A MX 9704253 A MX9704253 A MX 9704253A MX 9704253 A MX9704253 A MX 9704253A MX 9704253 A MX9704253 A MX 9704253A
- Authority
- MX
- Mexico
- Prior art keywords
- erythromycin
- antibiotic activity
- oxime derivatives
- derivatives endowed
- endowed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
La presente invencion describe compuestos de formula (I) en donde, A R2, M, n, m y r tiene los significados reportados en la descripcion, procesos para su preparacion y composiciones farmacéuticas que los contienen como ingredientes activos. Los compuestos de formula (I) son utiles en el tratamiento de enfermedades infecciosas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT94MI002496A IT1276901B1 (it) | 1994-12-13 | 1994-12-13 | Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica |
MIMI94A002496 | 1994-12-13 | ||
PCT/EP1995/004815 WO1996018633A1 (en) | 1994-12-13 | 1995-12-07 | Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9704253A true MX9704253A (es) | 1997-09-30 |
MXPA97004253A MXPA97004253A (es) | 1998-07-03 |
Family
ID=
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2183972A1 (en) | Oxazolidinone derivatives and pharmaceutical compositions containing them | |
AU6194694A (en) | Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
MD1233B1 (en) | Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof | |
AP9801253A0 (en) | 9-Oxime erythromycin derivatives. | |
AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
IL123551A0 (en) | Tricyclic erythromycin derivatives | |
CA2019404A1 (en) | 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents | |
IL94433A0 (en) | Aminophenol derivatives,their preparation and pharmaceutical compositions containing them | |
CA2219656A1 (en) | Antibacterial cephalosporins | |
BG101570A (en) | Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity | |
ATE15048T1 (de) | 4''-epi erythromycin a und seine derivate brauchbar wie antibakterielle mittel. | |
AU5290199A (en) | Erythromycin derivatives with antibiotic activity | |
CA2020346A1 (en) | Antibiotic ge 2270 factors a1, a2, a3 and h | |
GEP20032970B (en) | Pharmaceutical Compositions of Tizoxanide and Nitazoxanide | |
AP2001002325A0 (en) | Novel crystalline forms of a macrolide antibiotic | |
IE890748L (en) | Peptides with pharmaceutical activity | |
AU2067592A (en) | New n-(isoquinolin-5-ylsulphonyl)azacycloalkanes, process for the preparation thereof, and pharmaceutical compositions containing them | |
ATE23719T1 (de) | Rifamycinderivate, herstellung und diese enthaltende pharmazeutische zubereitungen. | |
MD970230A (en) | Diamine ether diclavulanate and process for preparation thereof | |
CA2133186A1 (en) | 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient | |
AU3138489A (en) | Peptides with pharmaceutical activity | |
ES8407057A1 (es) | Un procedimiento para la preparacion de un derivado de cefalosporina. | |
MX9805168A (es) | Derivados de tiol con actividad inhibitoria de la metalopeptidasa (ace-nep). | |
AU5508399A (en) | Erythromycin derivative with antibiotic activity | |
CA2235942A1 (en) | Tricyclic erythromycin derivatives |